Dashboard
1
Poor Management Efficiency with a low ROE of 6.82%
- The company has been able to generate a Return on Equity (avg) of 6.82% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.82%
3
The company has declared Negative results for the last 8 consecutive quarters
4
Risky - Negative EBITDA
Stock DNA
Miscellaneous
JPY 1,663 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.48
-12.92%
1.21
Revenue and Profits:
Net Sales:
400 Million
(Quarterly Results - Jun 2025)
Net Profit:
19 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.72%
0%
15.72%
6 Months
30.26%
0%
30.26%
1 Year
44.32%
0%
44.32%
2 Years
9.72%
0%
9.72%
3 Years
-29.93%
0%
-29.93%
4 Years
-5.4%
0%
-5.4%
5 Years
-16.31%
0%
-16.31%
PhoenixBio Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.29%
EBIT Growth (5y)
-48.37%
EBIT to Interest (avg)
-52.54
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.79
Tax Ratio
3.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.86%
ROE (avg)
6.82%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.16
EV to EBIT
-2.99
EV to EBITDA
-3.31
EV to Capital Employed
1.33
EV to Sales
0.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-44.46%
ROE (Latest)
-34.39%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
400.30
398.10
0.55%
Operating Profit (PBDIT) excl Other Income
31.00
20.00
55.00%
Interest
1.20
1.40
-14.29%
Exceptional Items
0.00
-275.50
100.00%
Consolidate Net Profit
19.20
-298.20
106.44%
Operating Profit Margin (Excl OI)
59.30%
28.30%
3.10%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.55% vs 12.11% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 106.44% vs -1,046.92% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
1,541.40
1,715.30
-10.14%
Operating Profit (PBDIT) excl Other Income
-107.00
29.80
-459.06%
Interest
5.20
2.90
79.31%
Exceptional Items
-275.50
-0.90
-30,511.11%
Consolidate Net Profit
-448.90
26.40
-1,800.38%
Operating Profit Margin (Excl OI)
-87.70%
2.60%
-9.03%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -10.14% vs -19.25% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -1,800.38% vs -94.65% in Mar 2024
About PhoenixBio Co., Ltd. 
PhoenixBio Co., Ltd.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






